The requirement for large quantities of therapeutic proteins has fuelled in
terest in the production of recombinant proteins in plants and animals. The
first commercial products to be made in this way have experienced much suc
cess, and it is predicted that in the future a plethora of protein products
will be made using these 'natural' bioreactors.